Literature DB >> 18241613

Genetic determinants of C-reactive protein.

Jacqueline Suk Danik1, Paul M Ridker.   

Abstract

C-reactive protein (CRP) levels are a complex phenotype with both genetic and environmental determinants. Recent work has highlighted the impact of genetic variants within the CRP gene as well as other candidate genes, often chosen for their role in the inflammatory pathway, on CRP levels. Emerging work shows the association of such genetic variants in CRP not only to CRP levels, but also to variation of CRP levels in the acute phase response. Work on the relation of genetic variants within CRP to cardiovascular disease has had varied results. Whole-genome association studies to investigate the genetic determinants of CRP levels in an unbiased manner are ongoing.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18241613     DOI： 10.1007/s11883-007-0019-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  77 in total

1.  C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.

Authors:  Isabella Kardys; Moniek P M de Maat; André G Uitterlinden; Albert Hofman; Jacqueline C M Witteman
Journal:  Eur Heart J       Date:  2006-05-03       Impact factor: 29.983

2.  Association between +1059G/C CRP polymorphism and acute myocardial infarction in a cohort of patients from Sicily: a pilot study.

Authors:  Carmela Rita Balistreri; Sonya Vasto; Florinda Listì; Maria Paola Grimaldi; Domenico Lio; Giuseppina Colonna-Romano; Marco Caruso; Gregorio Caimi; Enrico Hoffmann; Calogero Caruso; Giuseppina Candore
Journal:  Ann N Y Acad Sci       Date:  2006-05       Impact factor: 5.691

3.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

4.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.

Authors:  J S Pankow; A R Folsom; M Cushman; I B Borecki; P N Hopkins; J H Eckfeldt; R P Tracy
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

5.  Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors.

Authors:  C Eklund; T Lehtimäki; M Hurme
Journal:  Int J Immunogenet       Date:  2005-08       Impact factor: 1.466

6.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

7.  A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.

Authors:  Francesco Cipollone; Elena Toniato; Stefano Martinotti; Maria Fazia; Annalisa Iezzi; Chiara Cuccurullo; Barbara Pini; Sebastiano Ursi; Gianfranco Vitullo; Maurizio Averna; Marcello Arca; Anna Montali; Filomena Campagna; Sante Ucchino; Francesco Spigonardo; Stefano Taddei; Agostino Virdis; Giovanni Ciabattoni; Alberto Notarbartolo; Franco Cuccurullo; Andrea Mezzetti
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Authors:  Agnes Vatay; László Bene; Agota Kovács; Zoltán Prohászka; Csaba Szalai; László Romics; Béla Fekete; István Karádi; George Füst
Journal:  Immunogenetics       Date:  2003-06-14       Impact factor: 2.846

9.  Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study.

Authors:  Daniel Kelberman; E Hawe; L A Luong; Vidya Mohamed-Ali; Pia Lundman; Per Tornvall; M F Aillaud; Irène Juhan-Vague; John S Yudkin; Maurizio Margaglione; Giovanni di Minno; Elena Tremoli; Stephen E Humphries
Journal:  Thromb Haemost       Date:  2004-11       Impact factor: 5.249

10.  The extent of linkage disequilibrium in four populations with distinct demographic histories.

Authors:  A M Dunning; F Durocher; C S Healey; M D Teare; S E McBride; F Carlomagno; C F Xu; E Dawson; S Rhodes; S Ueda; E Lai; R N Luben; E J Van Rensburg; A Mannermaa; V Kataja; G Rennart; I Dunham; I Purvis; D Easton; B A Ponder
Journal:  Am J Hum Genet       Date:  2000-11-14       Impact factor: 11.043
View more
  13 in total

1.  Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspective.

Authors:  Sharad Gupta; Vitull K Gupta; Rupika Gupta; Sonia Arora; Varun Gupta
Journal:  Indian Heart J       Date:  2013-05-16

2.  C-reactive protein and risk of lung cancer.

Authors:  Anil K Chaturvedi; Neil E Caporaso; Hormuzd A Katki; Hui-Lee Wong; Nilanjan Chatterjee; Sharon R Pine; Stephen J Chanock; James J Goedert; Eric A Engels
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

3.  Association of tumor necrosis factor β genetic polymorphism and sepsis susceptibility.

Authors:  Francieli Delongui; Cíntia Magalhães Carvalho Grion; Maria Angelica Ehara Watanabe; Helena Kaminami Morimoto; Ana Maria Bonametti; Julie Massayo Maeda Oda; Ana Paula Kallaur; Tiemi Matsuo; Edna Maria Reiche
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

4.  C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.

Authors:  Francieli Delongui; Marcell Allyson Batisti Lozovoy; Tatiana Mayiumi Veiga Iriyoda; Neide Tomimura Costa; Nicole Perugini Stadtlober; Daniela Frizon Alfieri; Tamires Flauzino; Isaias Dichi; Andréa Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

5.  Effects of different doses of physical activity on C-reactive protein among women.

Authors:  Laura K Stewart; Conrad P Earnest; Steven N Blair; Timothy S Church
Journal:  Med Sci Sports Exerc       Date:  2010-04       Impact factor: 5.411

6.  Serum levels of high sensitive C reactive protein in healthy adults from southern Brazil.

Authors:  Francieli Delongui; Ana Paula Kallaur; Sayonara Rangel Oliveira; Ana Maria Bonametti; Cintia Magalhães Carvalho Grion; Helena Kaminami Morimoto; Andrea Name Colado Simão; Giuliana Gisele Magalhães; Edna Maria Vissoci Reiche
Journal:  J Clin Lab Anal       Date:  2013-02-20       Impact factor: 2.352

Review 7.  C-reactive protein as a predictor of disease in smokers and former smokers: a review.

Authors:  S Tonstad; J L Cowan
Journal:  Int J Clin Pract       Date:  2009-08-29       Impact factor: 2.503

8.  Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men.

Authors:  Elissa H Wilker; Stacey E Alexeeff; Audrey Poon; Augusto A Litonjua; David Sparrow; Pantel S Vokonas; Murray A Mittleman; Joel Schwartz
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

Review 9.  The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk.

Authors:  Fadi G Hage; Alexander J Szalai
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

10.  APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample.

Authors:  Jaroslav A Hubacek; Anne Peasey; Hynek Pikhart; Petr Stavek; Ruzena Kubinova; Michael Marmot; Martin Bobak
Journal:  Hum Immunol       Date:  2010-01-25       Impact factor: 2.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.